Chimaera and its modern virus-like descendants

Intervirology

Volumn 39, Issue 1-2, 1996, Pages 126-132

  Ulrich, Rainer ^a   Gerlich, Wolfram H ^b   Krüger, Detlev H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Baculovirus; Chimaera; Epitopes; Hepatitis B virus; Virus assembly; Virus like particles

Indexed keywords

EPITOPE; VACCINE;

ARTICLE; B LYMPHOCYTE; CHIMERA; COMPARATIVE STUDY; EXPRESSION VECTOR; IMMUNOGENICITY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; EUKARYOTIC CELLS; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; REASSORTANT VIRUSES; VACCINES, DNA; VACCINES, SYNTHETIC; VIRION;

ANIMALIA; CHIMAERA; CHIMAERIFORMES; HEPATITIS B VIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0029819376     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150484     Document Type: Article

References (108)

1. Burrell CJ, Mackay P, Greenaway PJ, Morschneider PH, Murray K: Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322, Nature 1979:296: 43-47.
2. Pasck M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K: Hepatitis B virus genes and their expression in E, coli, Nature 1979:282:575-579.
3. Edman JC, Hallcwell RA, Valenzuela P, Goodman HM, Rutter WJ: Synthesis of hepatitis B surface and core antigens in E, coli, Nature 1981;291:503-506.
4. Stahl S, MacKay P, Magazin M, Bruce SA, Murray K: Hepatitis B virus core antigen: Synthesis in E, coli and application in diagnosis, Proc Natl Acad Sei USA 1982;79:1606-1610.
5. Borisova GP, Pumpen PP, Bychko VV, Pushko PM, Kalis IV: Structure and expression in Escherichia coli cells of the core antigen gene of the human hepatitis B virus (HBV) (in Russian), Dokl Akad Nauk SSSR 1984:279:1245-1249.
6. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD: Synthesis and assembly of hepatitis B surface antigen particles in yeast, Nature 1982;298:347-350.
7. Harford H, Cabezón T, Crabeel M, Rutgers A, De Wilde M: Expression of hepatitis B surface antigen in yeast; in Dev Biol Standard Second WHO/IABS Symposium on Viral Hepatitis: Standardization in Immunoprophylaxis of Infections by Hepatitis B viruses, 1982, Basel, Karger, 1983, vol 54, pp 125-130.
8. Cohen BJ, Richmond JE: Electron microscopy of hepatitis B core antigen synthesized in E, coli, Nature 1982;296:677-678.
9. Milich DR, McLachlan A, Stahl S, Wingfield P, Thornton GB, Hughes JL, Jones JE: Comparative immunogenicity of hepatitis B virus core and e antigens, J Immunol 1988:141:3617-3624.
10. Jacobs E, Rutgers T, Voet OP, Dewerchin M, Cabezón T, de Wilde M: Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae, Gene 1989;80:279-291.
11. Adams SE, Mellor J, Gull K, Sim RB, Tuite MF, Kingsman SM, Kingsman AJ: The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins, Cell 1987;49:111-119.
12. Kozlovskaya TM, Pumpen PP, Drcilina DE, Tsimanis AI, Osc VP: Formation of capsid-like structures as a result of expression of the cloned gene of the envelope protein of the RNA-con-taining bacteriophage fr (in Russian), Dokl Akad Nauk SSSR 1986:287:452-455.
13. Mastico RA, Talbot SJ, Stockley PG: Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid, J Gen Virol 1993:74:541-548.
14. Jagadish MN, Ward CW, Gough KH, Tulloch PA, Whittaker LA, Shukla DD: Expression of potvvirus coal protein in Escherichia coli and yeast and its assembly into virus-like particles, j Gen Virol 1991:72:1543-1550.
15. Redmond MJ, Ohmann HB, Hughes PA, Sahara M, Frenchick PJ, Poku SK, Ijaz MK, Parker MD, Laarveld B, Babiuk LA: Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins, Mol Immunol 1991:28: 269-278.
16. Redmond MJ, Ijaz MK, Parker MD, Sahara ML Dent D, Gibbons E, Babiuk LA: Assembly of recombinant rotavirus proteins into viruslike particles and assessment of vaccine potential, Vaccine 1993;11:273-281.
17. Crawford SE, Labbc M, Cohen J, Burroughs MH, Zhou YJ, Estes MK: Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells, J Virol 1994:68:5945-5952.
18. Zeng CQ, Labbe M, Cohen J, Prasad BV, Chen D, Ramig RE, Estes MK: Characterization of rotavirus VP2 particles, Virology 1994:201: 55-65.
19. Ruffing M, Zcntgraf H, Klcinschmidl JA: Assembly of virus-like particles by recombinant structural proteins of adeno-associatcd virus type 2 in insect cells. J Virol 1992:66:6922-6930.
20. French TJ, Roy P: Synthesis of bluetonguc virus (B7 V) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV, J Virol 1990: 64:1530-1536.
21. French TJ, Marshall JJA, Roy P: Assembly of double-shelled, virus-like particles of blueton-gue virus by the simultaneous expression of four structural proteins, J Virol 1990:64:5695- 5700.
22. Rosen E, Stapleton JT, McLinden J: Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruscs, Vaccine 1993:11: 706-712.
23. Kimbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus LI major capsid protein self-asscmbles into virus-like particles that are highly immunogenic, Proc Natl Acad Sci USA 1992:89:12180-12184.
24. Rose RC, Bonncz W, Reichman RC, Garcca RL: Expression of human papilloma virus type 11 LI protein in insect cells: In vivo and in vitro assembly of virus-like particles, J Virol 1993;67:1936-1944.
25. Rose RC, Bonncz W, Da-Rin C, McCancc DJ, Reichman RC: Serological differentiation of human papillomavirus types II, 16 and 18 using recombinant virus-likc particles, J Gen Virol 1994:75:2445-2449.
26. Christensen ND, Ilopll R, DiAngelo SL, Cladel NM, Patrick SD, Welsh PA, Budgeon LR, Reed CA, Kreider JW: Assembled baculovirus-expresscd human papillomavirus type 11 LI capsid protein virus-like particles arc recognized by neutralizing monoclonal antibodies and induce high litres of neutralizing antibodies, J Gen Virol 1994:75:2271-2276.
27. Volpers C, Schirmacher P, Strecck RE, Sapp M: Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells, Virology 1994;200:504-512.
28. Le-Cann P, Coursaget P, lochmann S, Touze A: Self-assembly of human papillomavirus type 16 eapsids by expression of the LI protein in insect cells, FEMS Microbiol Lett 1994:117: 269-274.
29. Kajigaya S, Fujii H, Field A, Anderson S, Rev senfeld S, Anderson U, Shimada T, Young NS: Self-assembled B19 parvovirus eapsids, produced in a baculovirus system, are antigenical-ly and immunogcnically similar to native virions, Proc Natl Acad Sci USA 1991:88:4646-4650.
30. Saliki JT, Mizak B, Flore UP, Getting RR, Burand JP, Carmichael LE, Wood HA, Parrish CR: Canine parvovirus empty eapsids produced by expression in a baculovirus vector: Use in analysis of viral properties and immunization of dogs, J Gen Virol 1992:73:369-374.
31. Salimans MMM, van Bussel MJAWM, Brown CS, Spaan WJM; Recombinant parvovirus B19 eapsids as a new substrate for detection of B19-spccific IgG and IgM antibodies by an enzvmc-linked immunosorbent assay, J Virol Methods 1992;39:247-258.
32. Christensen J, Alexandersen S, Bloch B, Aasted B, Uttcmhal A: Production of mink enteritis parvovirus empty eapsids by expression in a baculovirus vector system: A recombinant vaccine for mink enteritis parvovirus in mink, J Gen Virol 1994;75:149-155.
33. Jiang X, Wang M, Graham DY, Estes MK: Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein, J Virol 1992; 66:6527-6532.
34. Fooks AR, Stephenson J R, Wames A, Dowsett AB, Rima BK, Wilkinson GWG: Measles virus nucleocapsid protein expressed in insect cells assembles into tiucleocapsid-like structures, J Gen Virol 1993;74:1439-1444.
35. Delchambre M, Gheysen D, Thines D, Thiriart C, Jacobs E, Verdin E, Horth M, Bumy A, Bex F: The gag precursor of simian immunodeficiency virus assembles into virus-likc particles, EM BO J 1989:8:2653-2660.
36. Gheysen D, Jacobs E, de Forcsta F, Thiriart C, Francottc M, Thines D, de Wilde M: Assembly and release of HIV-1 precursor Pr55gag viruslike particles from recombinant baculovirus-infccted insect cells, Cell 1989:59:103-112.
37. Luo L, Li Y, Kang CY: Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovi-rus-infectcd insect cells, Virology 1990:179: 874-880.
38. Rasmussen L, Battles JK, Ennis WH, Nagashi-ma K, Gonda MA: Characterization of virus-likc particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus, Virology 1990; 178:435-451.
39. Wagner R, Flicssbach H, Modrow S, von Brunn A, Wolf H, Böltz T, Gclderblom H: Expression of HIV-1 autologous p55 and p55/ gpl20-V3 core particles: A new approach in HIV vaccine development; in Brown F, Cha-nock RM, Ginsberg I IS, Lemer RA (eds): Vaccines 91, Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1991, pp 109-114.
40. Thomsen DR, Meyer AL, Post LE: Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system, J Gen Virol 1992:73:1819-1824.
41. Hughes BP, Booth TF, Belyaev AS, Mcllroy D, Jowctt J, Roy P: Morphogenetic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells, Virology 1993; 193:242-255.
42. Mason HS, Arntzen CJ: Transgenic plants as vaccine production systems, Trends Biotcch-nol 1995:13:388-392.
43. Michel M-L, Mancini M, Riviere Y, Dormont D, Tiollais P: T- and B-lvmphocytc responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/ hepatitis B surface antigen particles, J Virol 1990:64:2452-2455.
44. Michel M-L, Mancini M, Schlienger K, Tiollais P: Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes, Res Virol 1993:144:263-267.
45. Krausslich H-G, Ochsenbaucr C, Traenckner A-M, Mergcncr K, Fäcke M, Gclderblom HR, Bosch V: Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-I gag and env gene products with or without active HIV proteinase, Virology 1993:192:605-617.
46. Spearman P, Wang JJ, Van der Heyden N, Ratner L: Identification of human immunodeficiency virus type I gag protein domains essential to membrane binding and particle assembly, J Virol 1994:68:3232-3242.
47. Ilagensec ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 cap-sids by expression of the 1.1 protein alone or by coexpression of the LI and L2 capsid proteins, J Virol 1993;67:315-322.
48. Loucon T, Roy P: Assembly of five bluctongue virus proteins expressed by recombinant hacn-loviruses: Inclusion of the largest protein VP I in the core and virus-likc particles, Virology 1991:180:798-802.
49. Tanaka S, Roy P: Identification of domains in bluetonguc virus VP3 molecules essential for the assembly of virus cores, J Virol 1994:68: 2795-2802.
50. Thomsen DR, Roof LL, Homa FL: Assembly of herpes simplex virus (HSV) intermediate eapsids in insect cells infected with recombinant baculoviruscs expressing HSV capsid proteins J Virol 1994:68:2442-2457.
51. Tatman JD, Preston VG, Nicholson P, Elliott RM, Rixon FJ: Assembly of herpes simplex virus type I eapsids using a panel of recombinant baculoviruscs, J Gen Virol 1994:75:1101-1113.
52. Bräutigam S, Snezhkov E, Bishop DHL: Formation of poliovirus-like particles by recombinant baculoviruscs expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein, Virology 1993:192:512-524.
53. Schirmbeck R, Melber K, Mertens T, Rcimann J: Selective stimulation of murine cytotoxic T cell 3nd antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen, EurJ Immunol 1994;24:1088-1096.
54. Murray K, Bruce SA, H innen A, Wingfield P, van Eerd PMCA, de Reus A, Schellekens H: Hepatitis B virus antigens made in microbial cells immunise against viral infection, EMBO J 1984;3:645-650.
55. Murray K, Bruce SA, Wingfield P, van Eerd P, de Reus A, Schellekens H: Protective immunisation against hepatitis B with an internal antigen of the virus, J Med Virol 1987:23:101- 107.
56. Schödel F, Neckermann G, Peterson D, Fuchs K, Fuller S, Will H, Roggendorl'M: Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nuclcocapsid antigen protects woodchucks from woodchuck hepatitis virus infection, Vaccine 1993:11:624-628.
57. Bertling WM, Gareis M, Paspaleeva V, Zimmer A, Kreuter J, Nürnberg H, Harrer P: Use of liposomes, viral capsids and nanoparticles as DNA carriers, Biotcchnol Appl Biochem 1991; 13:390-405.
58. Bertling WM; Polyoma as transfer system for gene therapy (abstract): Workshop ‘Chimeric Virus-Like Particles as Vaccines', Berlin, 1995, p 53.
59. Sandig V, Forstova J, Hofmann C, Griffin BE, Strauss M: Recombinant polyoma and HBV particles as vehicles for gene transfer (abstract), Workshop 'Chimeric Virus-Like Particles as Vaccines’, Berlin, 1995, p 18.
60. Francis MJ, Hastings GZ, Brown AL, Grace KG, Rowlands DJ, Brown F, Clarke BE: Immunological properties of hepatitis B core antigen fusion proteins, Proc Natl Acad Sei USA 1990;87:2545-2549.
61. Milich DR, McLachlan A, Hughes JL, Jones JE, Stahl S, Wingfield P, Thornton GB: Characterization of the hepatitis B virus nucleocapsid as an immunologic carrier moiety; in Lern-er RA, Ginsberg H, Chanock RM, Brown F (eds): Vaccines 89, Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989, pp 37-42.
62. Griffiths JC, Berrie EL, Holdsworth LN, Moore JP, Harris SJ, Senior JM, Kingsman SM, Kingsman AJ, Adams SE: Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty virus like particles in a clinically relevant adjuvant, J Virol 1991:65:450-456.
63. Harris SJ, Gearing AJH, Layton GT, Adams SE, Kingsman AJ: Enhanced proliferative cellular responses to FIIV-1 V3 peptide and gp 120 following immunization with V3:Ty virus-like particles, Immunology 1992:77:315-321.
64. Griffiths JC, Harris SJ, Layton GT, Berrie EL, French TJ, Burns NR, Adams SE, Kingsman AJ: Hybrid human immunodeficiency virus gag particles as an antigen carrier system: Induction of cytotoxic T-cell and humoral responses by a gag:V3 fusion, J Virol 1993:67: 3191-3198.
65. Layton GT, Harris SJ, Gearing AJH, Hill-Per-kins M, Cole JS, Griffiths JC, Burns NR, Kingsman AJ, Adams SE: Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-likc particles, J Immunol 1993;151:1097-1107.
66. Del Val M, Schlicht H-J, Volkmer HJ, Messerlc M, Reddehase MJ, Koszinowski UH: Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single non-americ T-cell epitope, J Virol 1991:65:3641-3646.
67. Del Val M, Schlicht H-J, Ruppcrt T, Reddehase MJ, Koszinowski UH: Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein, Cell 1991;66: 1145-1153.
68. Wagner R, Boltz T, Demi L, Modrow S, Wolf H: Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gpl20 by pSS/Vi chimeric vaccinia viruses, J Gen Virol 1993:74:1261 -1269.
69. Borisova G, Arya B, Dislcrs A, Borschukova O, Tsibinogin V, Skrastina D, Eldarov MA, Pumpcns P, Skryabin KG, Grcns E: Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen, J Virol 1993:67:3696-3701.
70. Schodel F, Wirtz R, Peterson D, Hughes J, Warren R, Sadoff J, Milich D: Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes, J Exp Med 1994;180:1037-1046.
71. Tindle RW, Herd K, Londono P, Fernando GJP, Chatfield SN, Malcolm K, Dougan G: Chimeric hepatitis B core antigen particles containing B- and Th-epitopcs of human papillomavirus type 16 E7 protein induce specific antibodv and T-helper responses in immunised mice, Virology 1994:200:547-557.
72. Mills KHG, Kitchin PA, Mahon BP, Barnard AL, Adams SE, Kingsman SM, Kingsman AJ: FI IV p24-spccific helper T cell clones from immunized primates recognize highly conserved regions of HIV I, J Immunol 1990:144: 1677-1683.
73. Schodel F, Milich DR, Will H: Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination, J Immunol 1990:145:4317-4321.
74. Schodel F, Peterson D, Hughes J, Milich DR: Avirulcnt Salmonella expressing hybrid hepatitis B virus corc/pre-S genes for oral vaccination, Vaccine 1993; 11:143-148.
75. Haynes JR, Cunningham J, von Seefried A, Lenniek M, Garvlin RT, Shcn S-H: Development of a genetically-engineered, candidate polio vaccine employing the self-assembling properties of the tobacco mosaic virus coat protein, Biotechnology 1986:4:637-641.
76. Valenzuela P, Coit D, Medina-Selbv MA, Kuo CH, Van Nest G, Burke RL, Bull RL, Urdca MS, Graves PV: Antigen engineering in yeast: Synthesis and assembly of hybrid hepatitis B surface antigcn-herpcs simplex 1 gD particles, Biotechnology 1985;3:323-325.
77. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred A, Highfield PE, Rowlands DJ, Brown F: Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature 1987;330:381-384.
78. Borisova GP, Berzins I, Pushko PM, Pumpen P, Grcn EJ, Tsibinogin VV, Loseva V, Ose V, Ulrich R, Siakkou H, Rosenthal HA: Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface, FEBS Lett 1989:259:121-124.
79. Stahl SJ, Murray K: Immunogenicity of peptide fusions to hepatitis virus core antigen, Proc Natl Acad Sci USA 1989;86:6283-6287.
80. Adams SC, Dawson KM, Gull K, Kingsman SM, Kingsman AJ: The expression of hybrid HlV:Ty virus-like particles in yeast, Nature 1987;329:68-70.
81. Adams SE, Burns NR, Layton GT, Kingsman AJ: Hybrid Ty virus-like particles, Int Rev Im-munoi 1994; 11:133-141.
82. Wagner R, Demi L, Fliessbach H, Wanner CI, Wolf H: Assembly and extracellular release of chimeric Pr55gag retrovirus-like particles, Virology 1994:200:162-175.
83. Luo L, Li Y, Cannon PM, Kim S, Kang CY: Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies, Proc Natl Acad Sci USA 1992:89:10527-10531.
84. Belyaev AS, Roy P: Presentation of hepatitis B virus prcS2 epitope on bluetongue virus corelike particles, Virology 1992:190:840-844.
85. Brown CS, Welling-Wester S, Fcijlbricf M, Van Lent JWM, Spaan WJM: Chimeric parvovirus B19 capsids for the presentation of foreign epitopes, Virology 1994;198:477-488.
86. Borisova G, Bundulc M, Grinstein E, Dreilina D, Dreimane A, Kalis J, Kozlovskaya T, Loseva V, Ose V, Pumpen P, Pushko P, Snikcrc D, Stankevica E, Tsibinogin V, Gren EJ: Recombinant capsid structures for exposure of protein antigenic epitopes, Mol Gen (Life Sci Adv) 1987:6:169-174.
87. Valcgard K, Murray JB, Stocklcy PG, Stone-house NJ, Liljas L: Crystal structure of an RNA bacteriophage coat protcin-operator complex, Nature 1994:371:623-626.
88. Bundulc M, Tars K, Petrovskis I, Orna L: Studies of the structure of bacteriophage fr recombinant capsids using X-ray analysis (abstract), Workshop 'Chimeric Virus-Like Particles as Vaccines', Berlin, 1995, p 5.
89. Ulrich R, Borisova GP, Gren E, Berzin I, Pumpen P, Eckert R, Ose V, Siakkou H, Gren EJ, von Bachr R, Kruger DH: Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus I core antigen, Arch Virol 1992;126:321-328.
90. Yoshikawa A, Tanaka T, Hoshi Y, Kato N, Tachibana K, lizuka H, Machida A, Okamoto H, Yamasaki M, Miyakawa Y, Mayumi M: Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core pro-tein. J Virol 1993;67:6064-6070.
91. Schodel F, Moriarty AM, Peterson DL, Zheng J, Hughes JL, Will H, Lcturcq DJ, McGee JS, Milich DR: The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity, J Virol 1992;66:106-114.
92. Delpcyroux F, van Wenzel E, Blonde! B, Crainic R: Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles, J Virol 1990;64:6090-6100.
93. Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE: Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted, Vaccine 1991;9:595-601.
94. von Brunn A, Brand M, Rcichhubcr C, Morys-Wortmann C, Dcinhardt F, Schodel F: Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles, Vaccine 1993:11: 817-824.
95. Ferstandig Arnold G, Resnick DA, Li Y, Zhang A, Smith AD, Geislcr SC, Jacobo-Molina A, Lee WM, Webster RG, Arnold E: Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency virus, Virology 1994;198:703-708.
96. Almond JW, Burke KL: Poliovirus as a vector for the presentation of foreign antigens, Semin Virol 1990:1:11-20.
97. Usha R, Rohll JB, Spall VE, Shanks M, Maule AJ, Johnson JE, LomonossoffGP: Expression of an animal virus antigenic site on the surface of a plant virus particle, Virology 1993: 197:366-374.
98. Smith GP: Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface, Science 1985:228: 1315-1317.
99. Parmley SF, Smith GP: Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes, Gene 1988:73:305-318.
100. Scott JK, Smith GP: Searching for peptide ligands with an epitope library, Science 1990: 249:386-390.
101. Cwirla SE, Peters EA, Barrett RW, Dower WJ: Peptides on phage: A vast library of peptides for identifying ligands, Proc Natl Aead Sci USA 1990:87:6378-6382.
102. Barbas CF III, Kang AS, Lemer RA, Benkov-ic SJ: Assembly of combinatorial antibody libraries on phage surfaces: The gene III site, Proc Natl Acad Sci USA 1991:88:7978-7982.
103. Greenwood J, Willis AE, Perhant RN: Multiple display of foreign peptides on a filamentous bacteriophage, Peptides from Plasmodium falciparum circumsporozoite protein as antigens, J Mol Biol 1991:220:821-827.
104. Tsunetsugu-Yokota Y, Tatsumi M, Robert V, Devaux C, Spire B, Chermann J-C, Hirsch 1: Expression of an immunogenic region of HI V by a filamentous bacteriophage vector, Gene 1991:99:261-265.
105. Moss B: Poxviruses as eukaryotic expression vectors, Semin Virol 1992;3:277-283.
106. Grunhaus A, Horwitz MS: Adenoviruses as cloning vectors, Semin Virol 1992:3:237- 252.
107. Vogel FR, Sarver N: Nucleic acid vaccines, Clin Microbiol Rev 1995;8:406-410.
108. Major ME, Vivitski L, Mink MA, Schlccf M, Whalen RG, Trepo C, Inchauspc G: DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C vims nucleocapsid, J Virol 1995;69:5798-5805.